52
Participants
Start Date
January 31, 2005
Primary Completion Date
September 30, 2008
Study Completion Date
January 31, 2009
Survanta (beractant)
beractant 4.0 ml/kg/dose (100 mg phospholipid/kg/dose, intratracheal, every 6-12 hours as needed for respiratory distress syndrome for initial and subsequent doses, maximum of 4 doses)
Curosurf (poractant)
poractant alfa 2.5 ml/kg/dose initial (200 mg phospholipid/kg), and 1.25 ml/kg/dose subsequent (100 mg/kg/subsequent dose), intratracheal, every 12-24 hours as needed for respiratory distress syndrome, maximum of 3 doses)
Boston Medical Center, Boston
Collaborators (1)
Dey LP
UNKNOWN
Alan Fujii
OTHER